La Jolla Meets ATHOS-3 Trial Endpoints, Dispels Market Controversy In The Process
May 22, 2017 at 09:34 AM EDT
Shares of La Jolla Pharmaceutical Company (NASDAQ: LJPC) were trading lower by more than 8 percent Monday morning after the company ...
